Literature DB >> 19478636

Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease.

Jeong-Hwa Hwang1, Shigeki Misumi, Hakan Sahin, Kevin K Brown, John D Newell, David A Lynch.   

Abstract

OBJECTIVE: To compare the computed tomographic (CT) features of idiopathic fibrosing interstitial pneumonia with those of pulmonary fibrosis related to collagen vascular disease (CVD).
METHODS: We reviewed the CT scans of 177 patients with diffuse interstitial pulmonary fibrosis, of which 97 had idiopathic fibrosing interstitial pneumonia and 80 had CVD. The CT images were systematically scored for the presence and extent of pulmonary and extrapulmonary abnormalities. Computed tomographic diagnosis of usual interstitial pneumonia (UIP) or nonspecific interstitial pneumonia (NSIP) was assigned.
RESULTS: A CT pattern of UIP was identified in 59 (60.8%) of patients with idiopathic fibrosing interstitial pneumonia compared with 15 (18.7%) of those patients with CVD; conversely, the CT diagnosis of NSIP was made in 51 (64%) of patients with CVD compared with 36 (37%) of patients with idiopathic disease (P < 0.01). In 113 patients who had lung biopsy, the CT diagnoses of UIP and NSIP were concordant with the histologic diagnoses in 36 of 50 patients and 34 of 41 patients, respectively. Pleural effusions, esophageal dilation, and pericardial abnormalities were more frequent in patients with CVD than in patients with idiopathic fibrosing interstitial pneumonia.
CONCLUSIONS: Compared with patients with CVD, those patients with an idiopathic fibrosing interstitial pneumonia showed a higher prevalence of a UIP pattern and lower prevalence of an NSIP pattern as determined by CT. Identification of coexisting extrapulmonary abnormalities on CT can support a diagnosis of CVD.

Entities:  

Mesh:

Year:  2009        PMID: 19478636     DOI: 10.1097/RCT.0b013e318181d551

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  12 in total

1.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

2.  Screening for Myositis Antibodies in Idiopathic Interstitial Lung Disease.

Authors:  Lee Fidler; Irena Doubelt; Sonja Kandel; Jolene H Fisher; Shikha Mittoo; Shane Shapera
Journal:  Lung       Date:  2019-03-05       Impact factor: 2.584

3.  Idiopathic pulmonary fibrosis complicated by acute thromboembolic disease: chest X-ray, HRCT and multi-detector row CT angiographic findings.

Authors:  Luigi Camera; Francesco Campanile; Massimo Imbriaco; Renato Ippolito; Cesare Sirignano; Ciro Santoro; Maurizio Galderisi; Marco Salvatore
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

4.  Interstitial Pneumonia with Autoimmune Features: Overview of proposed criteria and recent cohort characterization.

Authors:  Cathryn T Lee; Justin M Oldham
Journal:  Clin Pulm Med       Date:  2017-09

Review 5.  Cyclophosphamide for connective tissue disease-associated interstitial lung disease.

Authors:  Hayley Barnes; Anne E Holland; Glen P Westall; Nicole Sl Goh; Ian N Glaspole
Journal:  Cochrane Database Syst Rev       Date:  2018-01-03

6.  Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger?

Authors:  Petal A Wijnen; Johny A Verschakelen; Aalt Bast; Otto Bekers; Marjolein Drent
Journal:  Lung       Date:  2012-11-13       Impact factor: 2.584

7.  Connective Tissue Disease-associated Interstitial Lung Disease: A review.

Authors:  Markus Gutsche; Glenn D Rosen; Jeffrey J Swigris
Journal:  Curr Respir Care Rep       Date:  2012-09-21

8.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

Authors:  William D Travis; Ulrich Costabel; David M Hansell; Talmadge E King; David A Lynch; Andrew G Nicholson; Christopher J Ryerson; Jay H Ryu; Moisés Selman; Athol U Wells; Jurgen Behr; Demosthenes Bouros; Kevin K Brown; Thomas V Colby; Harold R Collard; Carlos Robalo Cordeiro; Vincent Cottin; Bruno Crestani; Marjolein Drent; Rosalind F Dudden; Jim Egan; Kevin Flaherty; Cory Hogaboam; Yoshikazu Inoue; Takeshi Johkoh; Dong Soon Kim; Masanori Kitaichi; James Loyd; Fernando J Martinez; Jeffrey Myers; Shandra Protzko; Ganesh Raghu; Luca Richeldi; Nicola Sverzellati; Jeffrey Swigris; Dominique Valeyre
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

Review 9.  State of the art in the diagnosis and management of interstitial lung disease.

Authors:  Maria T A Buzan; Carmen Monica Pop
Journal:  Clujul Med       Date:  2015-04-15

Review 10.  Usual interstitial pneumonia-pattern fibrosis in surgical lung biopsies. Clinical, radiological and histopathological clues to aetiology.

Authors:  Maxwell Smith; Mercedes Dalurzo; Prasad Panse; James Parish; Kevin Leslie
Journal:  J Clin Pathol       Date:  2013-05-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.